BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes
NCT ID: NCT05986253
Last Updated: 2024-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
10 participants
INTERVENTIONAL
2023-08-07
2031-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Seaweed Extract on Blood Glucose Response to Sucrose
NCT05461560
Effects of Seaweed Extract on Postprandial Response to White Bread
NCT05460884
Efficacy of a Brown Seaweed Powder for Glycemic Control
NCT02853916
Novel Organic Kale Products for Prevention of Obesity/Type 2 Diabetes
NCT04298970
The Effect of Chlorella Supplementation on Patients With Type 2 Diabetes Mellitus
NCT03625856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
0.6g/kg body mass maltodextrin in solution
Maltodextrin
maltodextrin solution
Protein
0.6g/kg body mass maltodextrin PLUS 0.15g/kg body mass protein from Biodulse, in solution
Seaweed protein
Novel protein extracted from seaweed
Maltodextrin
maltodextrin solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Seaweed protein
Novel protein extracted from seaweed
Maltodextrin
maltodextrin solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Exclusively receiving enteral or parenteral nutrition
* Any conditions/anomalies that are contraindications to bioelectrical impedance analysis as per institutional risk assessment and standard operating procedures
* Past medical history of cancer, neurological, kidney, pulmonary, digestive (Coeliac disease), thyroidal disease, cognitive impairment
18 Years
67 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Limerick
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian Carson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Limerick
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Limerick
Limerick, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23_05_07_EHS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.